Journal of Applied Oral Science

Repositório de dados e outros materiais relacionados com artigos em processo de avaliação para publicação ou publicados pelo periódico Journal of Applied Oral Science.

Antes de realizar qualquer depósito, consulte os Termos e condições de uso do repositório SciELO Data.

Repositorio de datos y otros materiales relacionados con artículos en proceso de evaluación para publicación o publicados por la revista Journal of Applied Oral Science .

Antes de realizar cualquier depósito, consulte el Términos y condiciones de uso de SciELO Data.

Data and other materials repository related to articles under evaluation for publication or publicated by the Journal of Applied Oral Science .

Before any deposit, consult the SciELO Data Terms and Conditions of Use.

Featured Dataverses

In order to use this feature you must have at least one published or linked dataverse.

Publish Dataverse

Are you sure you want to publish your dataverse? Once you do so it must remain published.

Publish Dataverse

This dataverse cannot be published because the dataverse it is in has not been published.

Delete Dataverse

Are you sure you want to delete your dataverse? You cannot undelete this dataverse.

401 to 410 of 720 Results

Supplementary_Table_07.tab Apr 17, 2023 - Data for: Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: A pilot study Tabular Data - 1.3 KB - 6 Variables, 34 Observations - UNF:6:piCeOO75bSmU64JGFpSMxQ== Table_S7 - Association between the immunoexpression frequencies of the metabolism-related biomarkers and the 3-year overall survival of oral squamous cell carcinoma patients.
Supplementary_Table_08.tab Apr 17, 2023 - Data for: Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: A pilot study Tabular Data - 3.7 KB - 25 Variables, 26 Observations - UNF:6:7FfBn6513qEhGxj/XaEwFw== Table_S8 - Association between the immunoexpression of metabolism-related biomarkers in hypoxic regions of the tissue sections and the clinicopathological data of oral squamous cell carcinoma patients.
Supplementary_Table_09.tab Apr 17, 2023 - Data for: Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: A pilot study Tabular Data - 1.0 KB - 6 Variables, 28 Observations - UNF:6:R9Z6sStsAXI2DmFJnYrM4A== Table_S9 - Association between the immunoexpression frequencies of the metabolism-related biomarkers in the hypoxic compartments of the malignant lesions and the 3-year disease-free survival of oral squamous cell carcinoma patients.
Supplementary_Table_10.tab Apr 17, 2023 - Data for: Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: A pilot study Tabular Data - 1.1 KB - 6 Variables, 28 Observations - UNF:6:PlLj1rq8Qrpg2zmiNBQcJQ== Table_S10. Association between the immunoexpression frequencies of the metabolism-related biomarkers in the hypoxic compartments of the malignant lesions and the 3-year overall survival of oral squamous cell carcinoma patients.
Table_1.tab Apr 17, 2023 - Data for: Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: A pilot study Tabular Data - 1.2 KB - 6 Variables, 38 Observations - UNF:6:aFt2yfbgTbU9nwKP5i8Q4g== Table_1 - Overview of clinicopathological data in patients with oral potentially malignant disorders.
Table_2.tab Apr 17, 2023 - Data for: Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: A pilot study Tabular Data - 813 B - 3 Variables, 33 Observations - UNF:6:Ali2OldQa6c5+RtMsKIBTw== Table_2 - Overview of clinicopathological data in patients with oral squamous cell carcinoma.
Table_3.tab Apr 17, 2023 - Data for: Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: A pilot study Tabular Data - 994 B - 14 Variables, 16 Observations - UNF:6:OgWjXmZlFyYsEZAfZLLFhQ== Table_3 - Immunoexpression frequencies of GLUT1, GLUT3, HK2, PFKL, PKM2, pPDH, LDHA, MCT4 and CAIX in oral potentially malignant disorders and in oral squamous cell carcinoma cases.
Table_4.txt Apr 17, 2023 - Data for: Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: A pilot study Plain Text - 1.2 KB - MD5: fba972cd268a9ad8579d6b666dd9917f Table_4 - Significant clinicopathological associations resulting from positive [or negative (-), when indicated] immunoexpression of GLUT1, GLUT3, HK2, PFKL, PKM2, pPDH, LDHA, MCT4 and CAIX in oral potentially malignant disorders and in oral squamous cell carcinoma cases (normoxi...
Table_4.xlsx Apr 17, 2023 - Data for: Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: A pilot study MS Excel Spreadsheet - 71.8 KB - MD5: 9f3dfb78d11afee8c33dafafda1b50db Table_4 - Significant clinicopathological associations resulting from positive [or negative (-), when indicated] immunoexpression of GLUT1, GLUT3, HK2, PFKL, PKM2, pPDH, LDHA, MCT4 and CAIX in oral potentially malignant disorders and in oral squamous cell carcinoma cases (normoxi...
Figure_1.jpg Mar 28, 2023 - Suppressing STAT3 activation impairs bone formation during maxillary expansion and relapse JPEG Image - 428.3 KB - MD5: 102bb332f5f3acc5742cc5a2881e884d Figure 1. Schematic diagram of expansion appliances used in the study. A, Inactivated expander. B, Activated expander. C, 100 g expansion force was exerted when the expander was installed on the occlusal surface of molars.

Supplementary_Table_07.tab

Apr 17, 2023 - Data for: Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: A pilot study

Tabular Data - 1.3 KB - 6 Variables, 34 Observations -

Table_S7 - Association between the immunoexpression frequencies of the metabolism-related biomarkers and the 3-year overall survival of oral squamous cell carcinoma patients.

Supplementary_Table_08.tab

Apr 17, 2023 - Data for: Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: A pilot study

Tabular Data - 3.7 KB - 25 Variables, 26 Observations -

Table_S8 - Association between the immunoexpression of metabolism-related biomarkers in hypoxic regions of the tissue sections and the clinicopathological data of oral squamous cell carcinoma patients.

Supplementary_Table_09.tab

Apr 17, 2023 - Data for: Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: A pilot study

Tabular Data - 1.0 KB - 6 Variables, 28 Observations -

Table_S9 - Association between the immunoexpression frequencies of the metabolism-related biomarkers in the hypoxic compartments of the malignant lesions and the 3-year disease-free survival of oral squamous cell carcinoma patients.

Supplementary_Table_10.tab

Apr 17, 2023 - Data for: Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: A pilot study

Tabular Data - 1.1 KB - 6 Variables, 28 Observations -

Table_S10. Association between the immunoexpression frequencies of the metabolism-related biomarkers in the hypoxic compartments of the malignant lesions and the 3-year overall survival of oral squamous cell carcinoma patients.

Table_1.tab

Apr 17, 2023 - Data for: Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: A pilot study

Tabular Data - 1.2 KB - 6 Variables, 38 Observations -

Table_1 - Overview of clinicopathological data in patients with oral potentially malignant disorders.

Table_2.tab

Apr 17, 2023 - Data for: Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: A pilot study

Tabular Data - 813 B - 3 Variables, 33 Observations -

Table_2 - Overview of clinicopathological data in patients with oral squamous cell carcinoma.

Table_3.tab

Apr 17, 2023 - Data for: Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: A pilot study

Tabular Data - 994 B - 14 Variables, 16 Observations -

Table_3 - Immunoexpression frequencies of GLUT1, GLUT3, HK2, PFKL, PKM2, pPDH, LDHA, MCT4 and CAIX in oral potentially malignant disorders and in oral squamous cell carcinoma cases.

Table_4.txt

Apr 17, 2023 - Data for: Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: A pilot study

Plain Text - 1.2 KB -

Table_4 - Significant clinicopathological associations resulting from positive [or negative (-), when indicated] immunoexpression of GLUT1, GLUT3, HK2, PFKL, PKM2, pPDH, LDHA, MCT4 and CAIX in oral potentially malignant disorders and in oral squamous cell carcinoma cases (normoxi...

Table_4.xlsx

Apr 17, 2023 - Data for: Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: A pilot study

MS Excel Spreadsheet - 71.8 KB -

Figure_1.jpg

Mar 28, 2023 - Suppressing STAT3 activation impairs bone formation during maxillary expansion and relapse

JPEG Image - 428.3 KB -

Figure 1. Schematic diagram of expansion appliances used in the study. A, Inactivated expander. B, Activated expander. C, 100 g expansion force was exerted when the expander was installed on the occlusal surface of molars.

Add Data

Share Dataverse

Link Dataverse

Reset Modifications